<p>Stoke Therapeutics Inc. has granted stock options to eleven new employees, allowing them to purchase a total of 131,280 shares of common stock at an exercise price of $32.98 per share, equal to the company’s closing price on December 15, 2025. The options will vest over four years, with 25% vesting on the one-year anniversary of the vesting commencement date and the remaining shares vesting monthly over the next 36 months. The options have a ten-year term and are governed by the 2023 Inducement Plan and the respective stock option agreements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251216645098) on December 16, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

STOK

<p>Stoke Therapeutics Inc. has granted stock options to eleven new employees under its 2023 Inducement Plan. The options allow the purchase of 131,280 shares at $32.98 per share, vesting over four years. This announcement was made via Business Wire on December 16, 2025.</p>

Stoke Therapeutics Grants Stock Options to New Employees Under Inducement Plan